Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Hinsch Gylvin Lykke — ProQR Therapeutics N.V. insider: 1 transactions · InsiderLens

Home / Insiders / Hinsch Gylvin Lykke

Hinsch Gylvin Lykke

Director at ProQR Therapeutics N.V. · on record since Jun 2, 2026

Insider trading activity of Hinsch Gylvin Lykke

Transactions on record: 1; since Jun 30, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 30, 2026

Figures computed from official regulatory filings — methodology.

Companies where Hinsch Gylvin Lykke has traded

ProQR Therapeutics N.V.1 tx · Jun 30, 2026

Track record of Hinsch Gylvin Lykke

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hinsch Gylvin Lykke

Co-insiders of Hinsch Gylvin Lykke

Carreno-Gomez BegonaProQR Therapeutics N.V.
de Boer Daniel AntonProQR Therapeutics N.V.
Filius BartProQR Therapeutics N.V.
HEGGIE THERESAProQR Therapeutics N.V.
Hom DennisProQR Therapeutics N.V.
LAWTON ALISON FRANCISProQR Therapeutics N.V.
Maier Martin AlexanderProQR Therapeutics N.V.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Platenburg Gerardus JohannesProQR Therapeutics N.V.

Shannon James SamuelProQR Therapeutics N.V.

Valerio DomenicoProQR Therapeutics N.V.

Company	Filed	Type	Qty	Price	Value · USD	Src
ProQR Therapeutics N.V.	Jun 30, 2026	AwardD	14,595	0.00 USD	—	SEC